The In Situ Sequencing (ISS) reagent kit is designed to enable and increase the efficiency of ISS on virtually any tissue sample. According to the kit’s manufacturer, users will be able to analyze either fresh/fixed frozen or formalin-fixed paraffin-embedded (FFPE) samples and rapidly create single-cell gene expression maps of up to 600 genes. The new ISS technology can facilitates various kinds of cancer research, including immuno-oncology research. As noted by the manufacturer, the new kit products contain improved probing and sequencing technologies and come with easy-to-follow protocols for library preparation and sequencing, respectively.
